DAIICHI SANKYO COMPANY, LIMITED

Consensus Daiichi Sankyo Company, Limited

Equities

4568

JP3475350009

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:31:52 19/06/2025 BST			5-day change	1st Jan Change
3,370.00 ^JPY	-2.43%		-6.62%	-22.52%

03:28am	Japan's Nikkei retreats from 4-month high as threat of US involvement in Iran conflict looms	RE
06-18	IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer	CI

Evolution of the Average Target: Daiichi Sankyo Company, Limited

Evolution of the Target Price: Daiichi Sankyo Company, Limited

Changes in Analyst Recommendations: Daiichi Sankyo Company, Limited

e83998d5cf551d3a8ce07.lM7TaTRceAWdgMsfHfEgVwSrACVA6csY4BE-Mo-RY10.9p2hHk0rSHX3t7xcbqAVZWHcYV13iKgttXdfVf3UNj7HhbwrTQ80RNHI-w~2da4e2df8a5fadbda6cb611171b5627b

Analysts' recommendations: Daiichi Sankyo Company, Limited

Jefferies Adjusts Daiichi Sankyo's Price Target to 6,000 Yen From 7,600 Yen, Keeps at Buy	04-02	MT
Jefferies Adjusts Daiichi Sankyo's Price Target to 7,600 Yen From 6,600 Yen, Keeps at Buy	04/09/24	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy	24/05/24	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy	21/02/24	MT
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen	04/12/23	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold	23/10/23	MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen	25/09/23	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy	13/07/23	MT
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy	14/12/22	MT
MarketScreener's World Press Review : June 6, 2022	06/06/22

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus (Composite)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
	DAIICHI SANKYO COMPANY, LIMITED					+69.11%
	ELI LILLY AND COMPANY					+21.27%
	JOHNSON & JOHNSON					+12.24%
	NOVO NORDISK A/S					+37.39%
	ABBVIE INC.					+12.6%
	ROCHE HOLDING AG					+16.8%
	NOVARTIS AG		-			+2.14%
	ASTRAZENECA PLC					+26.04%
	MERCK & CO., INC.					+28.37%
	AMGEN INC.					+8.65%
	Average					+23.46%
	Weighted average by Cap.					+19.98%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

17

Last Close Price

3,454.00JPY

Average target price

5,841.18JPY

Spread / Average Target

+69.11%

High Price Target

6,550.00JPY

Spread / Highest target

+89.64%

Low Price Target

4,500.00JPY

Spread / Lowest Target

+30.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.

Ratings

Trading Rating

Investor Rating

ESG MSCI

AAA

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Equities
4568 Stock
Consensus Daiichi Sankyo Company, Limited

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!